Global quest underway to speed COVID-19 vaccine trials – Reuters
- Date: 20-Jul-2021
- Source: Reuters
- Sector:Healthcare
- Country:Jordan
Global quest underway to speed COVID-19 vaccine trials – Reuters
CHICAGO, July 20 (Reuters) - Scientists are working on a benchmark for COVID-19 vaccine efficacy that would allow drugmakers to conduct smaller, speedier human trials to get them to market and address a huge global vaccine shortage.
Researchers are trying to determine just what level of COVID-19 antibodies a vaccine must produce to provide protection against the illness. Regulators already use such benchmarks - known as correlates of protection - to evaluate flu vaccines without requiring large, lengthy clinical trials.
"You could use it to predict efficacy from a vaccine, which will be more important as we are less able to conduct placebo-controlled trials," said Stanley Plotkin, inventor of the Rubella vaccine and an expert on correlates of protection.
Select Sector 
Select Country 
